Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Current theories about the mechanisms of benzodiazepines and neuroleptic drugs Richter JJAnesthesiology 1981[Jan]; 54 (1): 66-72The data reviewed above are the basis for the models of drug action proposed by neuropharmacologists. Mechanisms of benzodiazepine action are currently attributed to increased inhibitory neurotransmission. Costa and Guidotti26 proposed that anticonvulsant and sedative properties are a consequence of enhanced inhibitory neurotransmission mediated by GABA. Muscle relaxation may result from glycinemimetic actions of benzodiazepines in the spinal cord. Antianxiety mechanisms may be effects of both glycine- and GABA-mediated inhibition of specific neuronal pathways in the brainstem and brain (see fig. 2). Antipsychotic and extrapyramidal effects of neuroleptic drugs may be a consequence of their action at dopaminergic receptors.|Antipsychotic Agents/*pharmacology[MESH]|Benzodiazepines/*pharmacology[MESH]|Binding Sites[MESH]|Brain/metabolism[MESH]|Dopamine/physiology[MESH]|Glutamate Decarboxylase/metabolism[MESH]|Glycine/physiology[MESH]|Humans[MESH]|Neurotransmitter Agents/pharmacology[MESH]|Receptors, Dopamine/drug effects[MESH]|Receptors, Drug/metabolism[MESH]|Synaptic Membranes/metabolism[MESH]|Synaptic Transmission/*drug effects[MESH]|gamma-Aminobutyric Acid/physiology[MESH] |
